Luying Zeng

Title: Luying Zeng: Innovator in Gene Therapy

Introduction

Luying Zeng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. His innovative work has led to the development of a unique vector that holds promise for treating Bietti's crystalline dystrophy.

Latest Patents

Luying Zeng holds 1 patent for his invention titled "Vector and method for treating Bietti's crystalline dystrophy." This patent describes a vector that comprises a polynucleotide encoding CYP4V2 and a promoter operably linked to this polynucleotide. The vector demonstrates a good expression effect, high expression speed, and stable expression intensity. Additionally, the application provides cells, pharmaceutical compositions, and kits that utilize the vector, along with methods for treating, alleviating, and preventing diseases associated with retinal pigment epithelium (RPE) atrophy.

Career Highlights

Luying Zeng is associated with Chigenovo Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for retinal disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Luying Zeng collaborates with notable colleagues, including Liping Yang and Shaohong Chen. Their combined expertise enhances the research efforts at Chigenovo Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Luying Zeng's contributions to gene therapy, particularly in the treatment of retinal diseases, highlight his role as a leading inventor in the field. His innovative vector for treating Bietti's crystalline dystrophy represents a significant advancement in medical science.